Français

Contact us in Ontario


The Ontario Region takes in a large collection of towns and cities that are home to a diverse and ever-growing population. Ontario is the home of a strong community of volunteers, donors and sponsors, as well as an innovative team of researchers and healthcare professionals. These people are the heart and soul of our organization, and there are so many exciting ways to get involved! Every volunteer, donor, researcher and sponsor helps us to improve the lives of those affected by Crohn’s disease and ulcerative colitis, and brings us closer to finding cures.

Development Coordinator, Eastern Ontario
Vacant

Development Coordinator, Central Ontario
Cindy Weiss

416-920-5035 ext. 239

Development Coordinator, Southwestern Ontario
Shie Gorman

519-496-6703

Development Coordinator, Toronto
Kate Zahnow

1-800-387-1479

Development Coordinator, Northern Ontario
Nicole Sage

705-890-9782

Events

Woman sitting a table with a laptop taking notes

Canada Wide Peer Connect Event

Ready to connect with those who understand the challenges of Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)?   Join our upcoming Peer Connect ...

 • 
Virtual
 • 
Runners at the 2025 Toronto Waterfront Marathon

2025 Toronto Waterfront Marathon

Crohn’s and Colitis Canada is once again an official charity partner of the Toronto Waterfront Marathon! Whether you’re a seasoned runner, a casual walker, or simply looking to support a ...

 • 
5K Start Line Location: University Ave between Armoury St. and King St. Marathon and Half Marathon Start Line Location: University Ave between Armoury St & King St
Toronto
 • 
Remember to bookmark this page.

Toronto Office

2110-439 University Avenue
Toronto, ON M5G 1Y8

416-920-5035 or 1-800-387-1479

Search by Postal Code

News

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

 15 16 17 18 19 20 21 22 23 24